0001104659-20-137055.txt : 20201217 0001104659-20-137055.hdr.sgml : 20201217 20201217214644 ACCESSION NUMBER: 0001104659-20-137055 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201217 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MATLIN DAVID J CENTRAL INDEX KEY: 0001251956 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39813 FILM NUMBER: 201397845 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MedTech Acquisition Corp CENTRAL INDEX KEY: 0001826667 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 853009869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 BUSINESS PHONE: 6462096063 MAIL ADDRESS: STREET 1: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 3 1 tm2038870-2_3.xml OWNERSHIP DOCUMENT X0206 3 2020-12-17 0 0001826667 MedTech Acquisition Corp MTACU 0001251956 MATLIN DAVID J C/O MEDTECH ACQUISITION CORPORATION 600 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10022 1 1 1 0 Chief Financial Officer Class B Common Stock Class A Common Stock 6325000 I See Footnote As described in the issuer's registration statement on Form S-1 (File No. 333-251037), as amended (the "Registration Statement") under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, will automatically be converted into shares of Class A common stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments described therein and have no expiration date. These shares represent Class B common stock held by MedTech Acquisition Sponsor LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Sponsor and the issuer. The Class B common stock owned by the Sponsor includes up to 825,000 shares that are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the issuer's Registration Statement. The share data in this report reflects a 1.1-for-1 stock dividend for each share of Class B common stock outstanding effected by the issuer on December 17, 2020. As one of the managing members of the Sponsor, the reporting person may be deemed to share beneficial ownership of the shares of Class B common stock held directly by the Sponsor and disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. /s/ David J. Matlin 2020-12-17